Kits for detection of segmented negative strand RNA viruses
AssigneesWashington University, Apath, LLC
InventorsAndrew S. Pekosz, Paul D. Olivo
Life of this patent
Estimating the term…
Loading patent…
AssigneesWashington University, Apath, LLC
InventorsAndrew S. Pekosz, Paul D. Olivo
Estimating the term…
The present invention provides compositions and methods for the detection of the presence, absence, or quantity of a segmented negative strand RNA virus such as an influenza virus. A genetically engineered vertebrate cell comprising an artificial segment comprising a 5′ UTR and a 3′ UTR of a segmented negative strand RNA virus and an open reading frame of a reporter gene, preferably in an anti-sense orientation, is contacted with a biological specimen suspected of comprising a segmented negative strand virus. Infection of the cell with a segmented negative strand RNA virus results in expression of a polypeptide encoded by the reporter gene. A genetically engineered cell of the invention can also comprise a recombinant DNA encoding the artificial segment. The recombinant DNA can comprise a promoter for RNA Polymerase I for directing transcription of the artificial segment.
A kit for detecting the presence, absence, or quantity of an influenza virus, the kit comprising instructions and a genetically engineered cell that is stably transfected with an isolated recombinant DNA molecule, the isolated recombinant molecule comprising in 5′ to 3′ order:
Dependencies are inferred from the claim text.